Tapewire

NYSE · USD

USNA

USANA HEALTH SCIENCES INC

Export transactions ↓
Tapewire entity
6114
SEC CIK
0000896264
Parsed reports
821

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202600
Feb 202601
Mar 202602
Apr 202600
May 202604
Jun 202605
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2018 Filed Oct 2, 2018 16:50 UTC Exercise / conversionRestricted Stock Unit · Derivative 282 $0.00 $0.00
Disclosure

SEC source: 0001179110-18-011813 · edgar.xml · derivative · entry 3

AUCIAUX ROBERT · CIK 0001203342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 564

Underlying: Common Stock · 282 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter.

F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter.

Read SEC document
September 30, 2018 Filed Oct 2, 2018 16:50 UTC Tax withholdingCommon Stock 85 $120.00 $10,200.00
Disclosure

SEC source: 0001179110-18-011813 · edgar.xml · nonDerivative · entry 2

AUCIAUX ROBERT · CIK 0001203342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 394

Read SEC document
September 30, 2018 Filed Oct 2, 2018 16:50 UTC Exercise / conversionCommon Stock 282 Not disclosed Not disclosed
Disclosure

SEC source: 0001179110-18-011813 · edgar.xml · nonDerivative · entry 1

AUCIAUX ROBERT · CIK 0001203342 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

Read SEC document
September 14, 2018 Filed Sep 14, 2018 21:34 UTC Exercise / conversionStock Settled Stock Appreciation Rights · Derivative 6,960 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011432 · edgar.xml · derivative · entry 6

Guest Kevin · CIK 0001353496 · C.E.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,191

Underlying: Common Stock · 6,960 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 14, 2018 Filed Sep 14, 2018 21:34 UTC SaleCommon Stock 3,172 $130.15 $412,819.94
Disclosure

SEC source: 0001179110-18-011432 · edgar.xml · nonDerivative · entry 4

Guest Kevin · CIK 0001353496 · C.E.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 791

F2 · price: Weighted average price $130.145. Price range in multiple transactions was $130.00 to $130.275 inclusively.

Read SEC document
September 14, 2018 Filed Sep 14, 2018 21:34 UTC Exercise / conversionCommon Stock 3,172 $70.75 $224,403.14
Disclosure

SEC source: 0001179110-18-011432 · edgar.xml · nonDerivative · entry 3

Guest Kevin · CIK 0001353496 · C.E.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,963

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.

Read SEC document
September 13, 2018 Filed Sep 14, 2018 21:34 UTC Exercise / conversionStock Settled Stock Appreciation Rights · Derivative 5,849 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011432 · edgar.xml · derivative · entry 5

Guest Kevin · CIK 0001353496 · C.E.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,151

Underlying: Common Stock · 5,849 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 13, 2018 Filed Sep 14, 2018 21:34 UTC SaleCommon Stock 2,666 $130.00 $346,580.00
Disclosure

SEC source: 0001179110-18-011432 · edgar.xml · nonDerivative · entry 2

Guest Kevin · CIK 0001353496 · C.E.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 791

Read SEC document
September 13, 2018 Filed Sep 14, 2018 21:34 UTC Exercise / conversionCommon Stock 2,666 $70.75 $188,606.17
Disclosure

SEC source: 0001179110-18-011432 · edgar.xml · nonDerivative · entry 1

Guest Kevin · CIK 0001353496 · C.E.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.

Read SEC document
September 12, 2018 Filed Sep 14, 2018 21:35 UTC
Foukas JoshuaChief Legal Officer
SaleCommon Stock 306 $129.27 $39,557.72
Disclosure

SEC source: 0001179110-18-011433 · edgar.xml · nonDerivative · entry 1

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 10, 2018 Filed Sep 10, 2018 21:37 UTC
Brown JimPresident & COO
Exercise / conversionStock - Settled Stock Appreciation Rights · Derivative 285 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011254 · edgar.xml · derivative · entry 7

Brown Jim · CIK 0001555707 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 285 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 10, 2018 Filed Sep 10, 2018 21:37 UTC
Brown JimPresident & COO
SaleCommon Stock 121 $123.74 $14,972.54
Disclosure

SEC source: 0001179110-18-011254 · edgar.xml · nonDerivative · entry 5

Brown Jim · CIK 0001555707 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 10, 2018 Filed Sep 10, 2018 21:37 UTC
Brown JimPresident & COO
Exercise / conversionCommon Stock 121 $70.75 $8,560.15
Disclosure

SEC source: 0001179110-18-011254 · edgar.xml · nonDerivative · entry 4

Brown Jim · CIK 0001555707 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II

Read SEC document
September 10, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
Exercise / conversionStock - Settled Stock Appreciation Rights · Derivative 5,873 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · derivative · entry 10

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,000

Underlying: Common Stock · 5,873 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 10, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
Exercise / conversionStock - Settled Stock Appreciation Rights · Derivative 6,629 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · derivative · entry 9

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,873

Underlying: Common Stock · 6,629 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 10, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
SaleCommon Stock 2,549 $125.53 $319,986.17
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · nonDerivative · entry 7

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F5 · price: Weighted average price $125.534. Price range in multiple transactions was $125.00 to $125.75 inclusively.

Read SEC document
September 10, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
Exercise / conversionCommon Stock 2,549 $70.75 $180,329.01
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · nonDerivative · entry 6

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II

Read SEC document
September 10, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
SaleCommon Stock 2,907 $126.01 $366,316.88
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · nonDerivative · entry 5

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F4 · price: Weighted average price $126.012. Price range in multiple transactions was $126.00 to $126.125 inclusively.

Read SEC document
September 10, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
Exercise / conversionCommon Stock 2,907 $70.75 $205,655.72
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · nonDerivative · entry 4

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,907

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II

Read SEC document
September 07, 2018 Filed Sep 10, 2018 21:37 UTC
Brown JimPresident & COO
Exercise / conversionStock - Settled Stock Appreciation Rights · Derivative 24,449 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011254 · edgar.xml · derivative · entry 6

Brown Jim · CIK 0001555707 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,285

Underlying: Common Stock · 24,449 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 07, 2018 Filed Sep 10, 2018 21:37 UTC
Brown JimPresident & COO
SaleCommon Stock 6,671 $125.34 $836,123.13
Disclosure

SEC source: 0001179110-18-011254 · edgar.xml · nonDerivative · entry 3

Brown Jim · CIK 0001555707 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: Weighted average price $125.337. Price range in multiple transactions was $125.00 to $125.70 inclusively.

Read SEC document
September 07, 2018 Filed Sep 10, 2018 21:37 UTC
Brown JimPresident & COO
SaleCommon Stock 3,829 $124.53 $476,817.71
Disclosure

SEC source: 0001179110-18-011254 · edgar.xml · nonDerivative · entry 2

Brown Jim · CIK 0001555707 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,671

F2 · price: Weighted average price $124.528. Price range in multiple transactions was $124.00 to $124.85 inclusively.

Read SEC document
September 07, 2018 Filed Sep 10, 2018 21:37 UTC
Brown JimPresident & COO
Exercise / conversionCommon Stock 10,500 $70.75 $742,822.50
Disclosure

SEC source: 0001179110-18-011254 · edgar.xml · nonDerivative · entry 1

Brown Jim · CIK 0001555707 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II

Read SEC document
September 07, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
Exercise / conversionStock - Settled Stock Appreciation Rights · Derivative 12,118 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · derivative · entry 8

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,502

Underlying: Common Stock · 12,118 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 07, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
SaleCommon Stock 3,758 $125.51 $471,662.82
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · nonDerivative · entry 3

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: Weighted average price $125.509. Price range in multiple transactions was $125.00 to $125.70 inclusively.

Read SEC document
September 07, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
SaleCommon Stock 1,446 $124.07 $179,405.22
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · nonDerivative · entry 2

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,758

F2 · price: Weighted average price $124.07. Price range in multiple transactions was $124.00 to $124.65 inclusively.

Read SEC document
September 07, 2018 Filed Sep 11, 2018 17:36 UTC
Macuga Daniel A.Chief Communications Officer
Exercise / conversionCommon Stock 5,204 $70.75 $368,156.98
Disclosure

SEC source: 0001179110-18-011271 · edgar.xml · nonDerivative · entry 1

Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II

Read SEC document
September 06, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 1,226 $125.41 $153,752.66
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 9

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,015,614

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F11 · price: Weighted average price. Price range in multiple transactions was $124.85 to $125.80, inclusive.

Read SEC document
September 06, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 2,627 $124.42 $326,851.34
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 8

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,016,840

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F10 · price: Weighted average price. Price range in multiple transactions was $123.85 to $124.80, inclusive.

Read SEC document
September 06, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 1,835 $123.28 $226,218.80
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 7

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,019,467

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F9 · price: Weighted average price. Price range in multiple transactions was $122.85 to $123.75, inclusive.

Read SEC document
September 06, 2018 Filed Sep 7, 2018 00:05 UTC SaleCommon Stock 1,226 $125.41 $153,752.66
Disclosure

SEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 9

WENTZ MYRON W · CIK 0001203301 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares owned of record by Gull Global Limited

Disclosed balance after: 10,015,614

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F12 · price: Weighted average price. Price range in multiple transactions was $124.85 to $125.80, inclusive.

F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.

Read SEC document
September 06, 2018 Filed Sep 7, 2018 00:05 UTC SaleCommon Stock 2,627 $124.42 $326,851.34
Disclosure

SEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 8

WENTZ MYRON W · CIK 0001203301 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares owned of record by Gull Global Limited

Disclosed balance after: 10,016,840

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F11 · price: Weighted average price. Price range in multiple transactions was $123.85 to $124.80, inclusive.

F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.

Read SEC document
September 06, 2018 Filed Sep 7, 2018 00:05 UTC SaleCommon Stock 1,835 $123.28 $226,218.80
Disclosure

SEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 7

WENTZ MYRON W · CIK 0001203301 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares owned of record by Gull Global Limited

Disclosed balance after: 10,019,467

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F10 · price: Weighted average price. Price range in multiple transactions was $122.85 to $123.75, inclusive.

F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:51 UTC
Foukas JoshuaChief Legal Officer
Exercise / conversionStock - Settles Stock Appreciation Right · Derivative 9,848 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011175 · edgar.xml · derivative · entry 6

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 9,848 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:51 UTC
Foukas JoshuaChief Legal Officer
SaleCommon Stock 4,183 $123.39 $516,132.00
Disclosure

SEC source: 0001179110-18-011175 · edgar.xml · nonDerivative · entry 4

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: Weighted average price $123.388. Price range in multiple transactions was $123.00 to $123.825 inclusively.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:51 UTC
Foukas JoshuaChief Legal Officer
Exercise / conversionCommon Stock 4,183 $70.75 $295,926.34
Disclosure

SEC source: 0001179110-18-011175 · edgar.xml · nonDerivative · entry 3

Foukas Joshua · CIK 0001748208 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:50 UTC Exercise / conversionStock - Settles Stock Appreciation Right · Derivative 169 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011174 · edgar.xml · derivative · entry 9

IIEKKING G DOUG · CIK 0001203346 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 169 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:50 UTC Exercise / conversionStock - Settles Stock Appreciation Right · Derivative 10,004 $0.00 Strike: $70.75 $0.00
Disclosure

SEC source: 0001179110-18-011174 · edgar.xml · derivative · entry 8

IIEKKING G DOUG · CIK 0001203346 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,169

Underlying: Common Stock · 10,004 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:50 UTC SaleCommon Stock 74 $126.00 $9,324.00
Disclosure

SEC source: 0001179110-18-011174 · edgar.xml · nonDerivative · entry 6

IIEKKING G DOUG · CIK 0001203346 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:50 UTC Exercise / conversionCommon Stock 74 $70.75 $5,235.13
Disclosure

SEC source: 0001179110-18-011174 · edgar.xml · nonDerivative · entry 5

IIEKKING G DOUG · CIK 0001203346 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:50 UTC SaleCommon Stock 4,296 $124.29 $533,949.84
Disclosure

SEC source: 0001179110-18-011174 · edgar.xml · nonDerivative · entry 4

IIEKKING G DOUG · CIK 0001203346 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F3 · price: Weighted average price $124.29. Price range in multiple transactions was $124.00 to $124.925 inclusively.

Read SEC document
September 06, 2018 Filed Sep 6, 2018 22:50 UTC Exercise / conversionCommon Stock 4,296 $70.75 $303,920.52
Disclosure

SEC source: 0001179110-18-011174 · edgar.xml · nonDerivative · entry 3

IIEKKING G DOUG · CIK 0001203346 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,296

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.

Read SEC document
September 05, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 5,483 $125.95 $690,583.85
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 6

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,021,302

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F8 · price: Weighted average price. Price range in multiple transactions was $125.85 to $126.20, inclusive.

Read SEC document
September 05, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 8,896 $125.39 $1,115,469.44
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 5

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,026,785

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F7 · price: Weighted average price. Price range in multiple transactions was $124.85 to $125.80, inclusive.

Read SEC document
September 05, 2018 Filed Sep 7, 2018 00:05 UTC SaleCommon Stock 5,483 $125.95 $690,583.85
Disclosure

SEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 6

WENTZ MYRON W · CIK 0001203301 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares owned of record by Gull Global Limited

Disclosed balance after: 10,021,302

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F9 · price: Weighted average price. Price range in multiple transactions was $125.85 to $126.20, inclusive.

F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.

Read SEC document
September 05, 2018 Filed Sep 7, 2018 00:05 UTC SaleCommon Stock 8,896 $125.39 $1,115,469.44
Disclosure

SEC source: 0001144204-18-048363 · tv502475_4.xml · nonDerivative · entry 5

WENTZ MYRON W · CIK 0001203301 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Shares owned of record by Gull Global Limited

Disclosed balance after: 10,026,785

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F8 · price: Weighted average price. Price range in multiple transactions was $124.85 to $125.80, inclusive.

F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.

Read SEC document
September 04, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 2,026 $129.97 $263,319.22
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 4

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,035,681

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F6 · price: Weighted average price. Price range in multiple transactions was $129.60 to $130.35, inclusive.

Read SEC document
September 04, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 6,179 $129.15 $798,017.85
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 3

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,037,707

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F5 · price: Weighted average price. Price range in multiple transactions was $128.60 to $129.55, inclusive.

Read SEC document
September 04, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 4,945 $128.11 $633,503.95
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 2

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,043,886

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

F4 · price: Weighted average price. Price range in multiple transactions was $127.60 to $128.55, inclusive.

Read SEC document
September 04, 2018 Filed Sep 7, 2018 00:03 UTC SaleCommon Stock 6,783 $127.06 $861,847.98
Disclosure

SEC source: 0001144204-18-048361 · tv502473_4.xml · nonDerivative · entry 1

Gull Global Ltd · CIK 0001636301 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,048,831

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: Weighted average price. Price range in multiple transactions was $126.60 to $127.55, inclusive.

F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.